Published in PLoS One on July 24, 2015
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell (1991) 8.75
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol (1991) 8.60
A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature (1998) 8.48
Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA (2003) 8.07
Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol (2003) 7.93
Cancer invasion and the microenvironment: plasticity and reciprocity. Cell (2011) 6.36
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res (2006) 5.90
The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell (2009) 3.87
The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res (2005) 3.65
Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell (2006) 3.28
Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol (2009) 2.89
Classifying collective cancer cell invasion. Nat Cell Biol (2012) 2.83
Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. J Pathol (2000) 2.61
E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res (2003) 2.61
Characterization of the interface between normal and transformed epithelial cells. Nat Cell Biol (2009) 2.21
Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study. Histopathology (2013) 2.05
A role for Rho GTPases and cell-cell adhesion in single-cell motility in vivo. Nat Cell Biol (2009) 2.05
Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov (2011) 1.88
Persistent E-cadherin expression in inflammatory breast cancer. Mod Pathol (2001) 1.73
E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol (2001) 1.68
Cell mechanics control rapid transitions between blebs and lamellipodia during migration. Proc Natl Acad Sci U S A (2012) 1.67
Breakdown of the endothelial barrier function in tumor cell transmigration. Biophys J (2007) 1.39
Production of epithelial and mesenchymal tumours with rat liver cells transformed in vitro. Int J Cancer (1975) 1.33
E-cadherin's dark side: possible role in tumor progression. Biochim Biophys Acta (2012) 1.32
Tre1 GPCR initiates germ cell transepithelial migration by regulating Drosophila melanogaster E-cadherin. J Cell Biol (2008) 1.23
Dynamic interplay between adhesive and lateral E-cadherin dimers. Mol Cell Biol (2002) 1.23
Evolution: structural and functional diversity of cadherin at the adherens junction. J Cell Biol (2011) 1.22
Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study. J Cell Sci (2010) 1.15
Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Histopathology (1996) 1.15
Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis. Cancer Treat Res (2009) 1.10
Vascular permeability changes involved in tumor metastasis. Cancer Lett (2013) 1.02
The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression. Differentiation (2007) 1.02
Rearrangements of the actin cytoskeleton and E-cadherin-based adherens junctions caused by neoplasic transformation change cell-cell interactions. PLoS One (2009) 0.99
Realtime visualization of tumor cell/endothelial cell interactions during transmigration across the endothelial barrier. J Cancer Res Clin Oncol (2002) 0.99
L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res (2010) 0.95
Endothelial permeability and VE-cadherin: a wacky comradeship. Cell Adh Migr (2014) 0.93
Role of O-glycosylation and expression of CD43 and CD45 on the surfaces of effector T cells in human T cell leukemia virus type 1 cell-to-cell infection. J Virol (2011) 0.90
Synthesis of junctional proteins in metastasizing colon cancer cells. Eur J Cell Biol (2005) 0.86
Proteolysis during tumor cell extravasation in vitro: metalloproteinase involvement across tumor cell types. PLoS One (2013) 0.85
Mechanical control of the endothelial barrier. Cell Tissue Res (2014) 0.84
E-cadherin in oral SCC: an analysis of the confusing literature and new insights related to its immunohistochemical expression. Histol Histopathol (2012) 0.79
An introduction to adherens junctions: from molecular mechanisms to tissue development and disease. Subcell Biochem (2012) 0.79
[Morphology, cell-cell interactions, and migratory activity of IAR-2 epithelial cells transformed with the RAS oncogene: contribution of cell adhesion protein E-cadherin]. Ontogenez (2012) 0.77